Sunshine Biopharma SBFM Q3 2024 earnings
Reported November 5, 2024 · Before market open
Revenue$8.4MMiss by $4.1M
EPS-$0.94Miss by $9.94
Revenue estimate$12.5M
EPS estimate$9.00
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$8.7M
EPS estimate-$1.20
Versus estimates
Revenue
Diluted EPS
Ask the moment Sunshine Biopharma reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Sunshine Biopharma report Q3 2024 earnings?
- Sunshine Biopharma (SBFM) reported Q3 2024 earnings on November 5, 2024 before market open.
- What were Sunshine Biopharma's Q3 2024 revenue and EPS?
- Sunshine Biopharma reported revenue of $8.4M and eps of $-0.94 for Q3 2024.
- Did Sunshine Biopharma beat estimates in Q3 2024?
- Revenue missed the consensus estimate of $12.5M by $4.1M. EPS missed the consensus estimate of $9.00 by $9.94.
- Where can I find Sunshine Biopharma's Q3 2024 SEC filings?
- You can read the 10-Q periodic report (0001683168-24-007622) directly on SEC EDGAR. The filing index links above go to sec.gov.